SCHEMBL3487966

SCHEMBL3487966

Cn1nccc1-c1ccc(F)cc1F

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 1/20 0.48
KDM5A P29375 1/20 0.48
KDM4C Q9H3R0 1/20 0.48
KDM5B Q9UGL1 1/20 0.48
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
AKT1 P31749 3/20 0.42
AKT2 P31751 1/20 0.42
COMT P21964 1/20 0.41
SCN9A Q15858 5/20 0.40
CYP1A2 P05177 1/20 0.40
METAP2 P50579 1/20 0.40
HTR2A P28223 3/20 0.39
KCNH2 Q12809 1/20 0.39
HTR2C P28335 1/20 0.39
BACE1 P56817 1/20 0.39
PDE4B Q07343 1/20 0.38
DPP4 P27487 1/20 0.38
GRM2 Q14416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24121175 0.83 ALDH1A1 (0.42) ALDH1A1MAPTCOMTSCN9ACYP1A2
SCHEMBL14189702 0.83 SCN9A (0.42) KDM4AKDM5AKDM4CKDM5BALDH1A1
SCHEMBL31148268 0.83 ALDH1A1 (0.42) KDM4AKDM5AKDM4CKDM5BALDH1A1
SCHEMBL26108533 0.80 SCN9A (0.42) ALDH1A1MAPTAKT1COMTSCN9A
SCHEMBL1095146 0.79 ALDH1A1 (0.49) ALDH1A1MAPTCOMTSCN9ACYP1A2
SCHEMBL27934966 0.79 GRM7 (0.44) MAPTSCN9ACYP1A2
SCHEMBL2274673 0.78 EGLN2 (0.44) ALDH1A1MAPTCOMTSCN9ACYP1A2
SCHEMBL3327593 0.78 KDM5A (0.54) KDM4AKDM5AKDM4CKDM5BALDH1A1
SCHEMBL22954772 0.78 ALDH1A1 (0.38) ALDH1A1MAPTAKT1AKT2COMT
SCHEMBL28999948 0.78 ATM (0.44) ALDH1A1MAPTSCN9AHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100094000-A1 PYRAZOLE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-15 US disclosed
US-20100094000-A1 PYRAZOLE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-15 US disclosed
US-20100094000-A1 PYRAZOLE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100094000-A1 PYRAZOLE COMPOUNDS NR3C2, MC2R, NR3C1 KDM4A 3788/4885KDM5A 2105/4885KDM4C 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.